Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Lipids Health Dis ; 13: 17, 2014 Jan 22.
Article in English | MEDLINE | ID: mdl-24447440

ABSTRACT

Nichols et al. (Lipids Health Dis13:2, 2014) raised concern about the higher n-6 concentration in fish oil used in our recent study which is different from typical commercial fish oils (Ramprasath et al. Lipids Health Dis12:178, 2013). The aim of our study was to compare the effect of consumption of similar amount of n-3 PUFA from krill and fish oil with placebo on plasma and RBC fatty acids. As the concentration of n-3 PUFA in the fish oil utilised was higher than that in krill oil, we deemed it important to keep consistent the concentration of n-3 PUFA and volumes to be administered to participants between krill versus fish oils. As such, the fish oil used in the study was diluted with corn oil. Although the n-6 PUFA concentration in fish oil was higher compared to traditionally used fish oil, consumption of the fish oil used in our study actually reduced the total n-6 PUFA in plasma and RBC to a similar extent as did krill oil. Overall, our conclusion was that the increases in plasma and RBC concentrations of EPA and DHA along with improvement in the omega-3 index observed with consumption of krill oil compared with fish oil are due to differences in absorption and bioavailability based on the structural difference of the two oils rather than their n-6 PUFA content.


Subject(s)
Dietary Fats, Unsaturated/administration & dosage , Euphausiacea/chemistry , Fish Oils/administration & dosage , Animals , Female , Humans , Male
2.
Lipids Health Dis ; 12: 178, 2013 Dec 05.
Article in English | MEDLINE | ID: mdl-24304605

ABSTRACT

BACKGROUND: Due to structural differences, bioavailability of krill oil, a phospholipid based oil, could be higher than fish oil, a triglyceride-based oil, conferring properties that render it more effective than fish oil in increasing omega-3 index and thereby, reducing cardiovascular disease (CVD) risk. OBJECTIVE: The objective was to assess the effects of krill oil compared with fish oil or a placebo control on plasma and red blood cell (RBC) fatty acid profile in healthy volunteers. PARTICIPANTS AND METHODS: Twenty four healthy volunteers were recruited for a double blinded, randomized, placebo-controlled, crossover trial. The study consisted of three treatment phases including krill or fish oil each providing 600 mg of n-3 polyunsaturated fatty acids (PUFA) or placebo control, corn oil in capsule form. Each treatment lasted 4 wk and was separated by 8 wk washout phases. RESULTS: Krill oil consumption increased plasma (p = 0.0043) and RBC (p = 0.0011) n-3 PUFA concentrations, including EPA and DHA, and reduced n-6:n-3 PUFA ratios (plasma: p = 0.0043, RBC: p = 0.0143) compared with fish oil consumption. Sum of EPA and DHA concentrations in RBC, the omega-3 index, was increased following krill oil supplementation compared with fish oil (p = 0.0143) and control (p < 0.0001). Serum triglycerides and HDL cholesterol concentrations did not change with any of the treatments. However, total and LDL cholesterol concentrations were increased following krill (TC: p = 0.0067, LDL: p = 0.0143) and fish oil supplementation (TC: p = 0.0028, LDL: p = 0.0143) compared with control. CONCLUSIONS: Consumption of krill oil was well tolerated with no adverse events. Results indicate that krill oil could be more effective than fish oil in increasing n-3 PUFA, reducing n-6:n-3 PUFA ratio, and improving the omega-3 index. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01323036.


Subject(s)
Dietary Fats, Unsaturated/administration & dosage , Euphausiacea/chemistry , Fish Oils/administration & dosage , Adult , Animals , Cholesterol, HDL/blood , Corn Oil/administration & dosage , Cross-Over Studies , Dietary Fats, Unsaturated/isolation & purification , Docosahexaenoic Acids/blood , Double-Blind Method , Eicosapentaenoic Acid/blood , Female , Healthy Volunteers , Humans , Male , Triglycerides/blood
3.
Clin Interv Aging ; 8: 557-63, 2013.
Article in English | MEDLINE | ID: mdl-23723695

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of soybean-derived phosphatidylserine (SB-PS) (300 mg/day) in improving cognitive performance in elderly with memory complaints, following a short duration of 12 weeks' SB-PS administration. METHODS: SB-PS was administered daily for 12 weeks to 30 elderly volunteers with memory complaints (age range 50-90 years). Cognitive performance was determined by a computerized test battery and by the Rey Auditory Verbal Learning Test (Rey-AVLT). Physical examination and blood safety parameters were part of the extensive safety analysis of PS that was performed. RESULTS: The computerized test results showed that SB-PS supplementation significantly increased the following cognitive parameters: memory recognition (P = 0.004), memory recall (P = 0.006), executive functions (P = 0.004), and mental flexibility (P = 0.01). The Rey-AVLT indicated that, following SB-PS administration, total learning and immediate recall improved significantly (P = 0.013 and P = 0.007, respectively). Unexpected results from the safety tests suggested that SB-PS significantly reduces both systolic (P = 0.043) and diastolic (P = 0.003) blood pressure. SB-PS consumption was well tolerated and no serious adverse events were reported during the study. CONCLUSION: This exploratory study demonstrates that SB-PS may have favorable effects on cognitive function in elderly with memory complaints. In addition, the study suggests that SB-PS is safe for human consumption and may serve as a safe alternative to phosphatidylserine extracted from bovine cortex. These results encourage further extended studies in order to establish the safety and efficacy of SB-PS treatment.


Subject(s)
Glycine max/chemistry , Memory Disorders/drug therapy , Phosphatidylserines/therapeutic use , Aged , Aged, 80 and over , Analysis of Variance , Female , Geriatric Assessment , Humans , Male , Middle Aged , Neuropsychological Tests , Pilot Projects , Statistics, Nonparametric , Treatment Outcome
4.
Mech Dev ; 125(5-6): 396-410, 2008.
Article in English | MEDLINE | ID: mdl-18359204

ABSTRACT

Vertebrate embryos generate striking Ca(2+) patterns, which are unique regulators of dynamic developmental events. In the present study, we used zebrafish embryos as a model system to examine the developmental roles of Ca(2+) during gastrulation. We found that gastrula stage embryos maintain a distinct pattern of cytosolic Ca(2+) along the dorsal-ventral axis, with higher Ca(2+) concentrations in the ventral margin and lower Ca(2+) concentrations in the dorsal margin and dorsal forerunner cells. Suppression of the endoplasmic reticulum Ca(2+) pump with 0.5 microM thapsigargin elevates cytosolic Ca(2+) in all embryonic regions and induces a randomization of laterality in the heart and brain. Affected hearts, visualized in living embryos by a subtractive imaging technique, displayed either a reversal or loss of left-right asymmetry. Brain defects include a left-right reversal of pitx2 expression in the dorsal diencephalon and a left-right reversal of the prominent habenular nucleus in the brain. Embryos are sensitive to inhibition of the endoplasmic reticulum Ca(2+) pump during early and mid gastrulation and lose their sensitivity during late gastrulation and early segmentation. Suppression of the endoplasmic reticulum Ca(2+) pump during gastrulation inhibits expression of no tail (ntl) and left-right dynein related (lrdr) in the dorsal forerunner cells and affects development of Kupffer's vesicle, a ciliated organ that generates a counter-clockwise flow of fluid. Previous studies have shown that Ca(2+) plays a role in Kupffer's vesicle function, influencing ciliary motility and translating the vesicle's counter-clockwise flow into asymmetric patterns of gene expression. The present results suggest that Ca(2+) plays an additional role in the formation of Kupffer's vesicle.


Subject(s)
Brain/embryology , Calcium/physiology , Dyneins/biosynthesis , Endoplasmic Reticulum/metabolism , Gastrula/physiology , Heart/embryology , Sodium-Calcium Exchanger/biosynthesis , T-Box Domain Proteins/biosynthesis , Zebrafish Proteins/biosynthesis , Animals , Body Patterning , Calcium/metabolism , Dyneins/physiology , Fetal Proteins , Gene Expression Regulation, Developmental , In Situ Hybridization , Models, Biological , Sodium-Calcium Exchanger/physiology , T-Box Domain Proteins/physiology , Thapsigargin/pharmacology , Zebrafish , Zebrafish Proteins/physiology
5.
J Plant Physiol ; 160(11): 1375-84, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14658391

ABSTRACT

Acclimation of the halotolerant alga Dunaliella salina to low temperature induced the accumulation of a 12.4 kDa protein (DsGRP-1) and reduction of a 13.1 kDa protein (DsGRP-2). DsGRP-1 and DsGRP-2 are boiling-stable proteins that are localised in the cytoplasm, as revealed by sub-cellular fractionation and by immuno-localisation. The proteins were partially purified and their corresponding genes were cloned. The predicted sequences are homologous to Glycine-Rich RNA-binding Proteins (GRPs) from plants and cyanobacteria. The nucleotide sequences of grp1 and grp2 differ in a short insert encoding 9 amino acids in the glycine-rich domain of DsGRP-2. grp2 contains a single intron at position 179 indicating that DsGRP-1 and DsGRP-2 are not derived from alternative splicing of a common gene. The level of grp mRNA increased at 7 degrees C and was rapidly depressed at 24 degrees C. Analysis of binding to ribonucleotide homopolymers revealed that DsGRP-1 and DsGRP-2 bind preferentially to poly-G and to poly-U indicating that they are RNA-binding proteins. It is proposed that DsGRP-1 and DsGRP-2 are encoded by distinct genes which are differentially regulated by temperature.


Subject(s)
Adaptation, Physiological/physiology , Algal Proteins/genetics , Chlorophyta/physiology , Glycine/genetics , RNA-Binding Proteins/genetics , Sodium Chloride/pharmacology , Adaptation, Physiological/drug effects , Algal Proteins/metabolism , Amino Acid Sequence , Base Sequence , Chlorophyta/drug effects , Chlorophyta/genetics , Cloning, Molecular , Cold Temperature , DNA, Complementary/chemistry , DNA, Complementary/genetics , Immunohistochemistry , Light , Mass Spectrometry , Microscopy, Confocal , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA-Binding Proteins/metabolism , Sequence Analysis, DNA , Sequence Homology, Amino Acid
6.
J Plant Physiol ; 160(2): 185-92, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12685034

ABSTRACT

Cold-acclimation (CA) of the halotolerant alga Dunaliella was inhibited by light and by high salt. CA was associated with enhanced resistance to freezing in saline growth solutions, as manifested by protection of photosynthetic oxygen evolution and by reduced permeabilisation of the plasma membrane. Oxygen evolution activity in isolated chloroplasts was not affected by freezing, but was inhibited by high salt and the inhibition could be reversed or protected by glycerol. The activity of chloroplasts from cold-acclimated cells was more resistant to salt than of non-acclimated cells. Electron transport measurements in chloroplasts indicated that high salt inhibited PS-II, but not PS-I electron transport. High salt also inhibited PS-II thermoluminescence (TL) activity in chloroplasts. Similar inhibition of PS-II TL was observed by freezing intact cells in saline solutions. Chloroplasts from cold-acclimated cells had enhanced resistance to inhibition of PS-II electron transport and of PS-II TL by high salt. These results suggest that inhibition of oxygen evolution upon freezing Dunaliella cells may result from inactivation of PS-II due to massive influx of salt and loss of glycerol. The enhanced freeze-resistance of cold-acclimated cells to inhibition of oxygen evolution can be accounted for partly by protection of PS-II against high salt.


Subject(s)
Chlorophyta/metabolism , Photosynthetic Reaction Center Complex Proteins/metabolism , Acclimatization , Chlorophyta/drug effects , Chlorophyta/growth & development , Chlorophyta/radiation effects , Chloroplasts/metabolism , Cold Temperature , Freezing , Light , Osmotic Pressure , Oxygen/metabolism , Photosynthetic Reaction Center Complex Proteins/antagonists & inhibitors , Photosystem II Protein Complex , Sodium Chloride/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...